artículo académico

• Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.  Mucosal Immunology.  7:89-100. 2014
• Lentiviral vector followed by protein immunisation breaks tolerance against the self‐antigen Her1 and results in lung cancer immunotherapy.  The Journal of Gene Medicine.  14:151-157. 2012
• PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8 + T cells.  EMBO Molecular Medicine.  3:581-592. 2011
• Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis.  Arthritis & Rheumatology.  63:84-95. 2011
• Targeting Lentiviral Vectors for Cancer Immunotherapy.  Current Cancer Therapy Reviews.  7:248-260. 2011
• HIV-1 Lentiviral vector immunogenicity is mediated by Toll-Like Receptor 3 (TLR3) and TLR7.  Journal of Virology.  84:5627-5636. 2010
• Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization.  Molecular Therapy.  17:1643-1650. 2009